NCT02023411View on ClinicalTrials.gov

Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Diabetic Neuropathic Arthropathy
Interventions
DRUG

Teriparatide

recombinant human parathyroid hormone (1-34) subcutaneous every day at 8-9 pm

OTHER

Placebo

Placebo

Trial Locations (2)

160012

Deptt of Endocrinology, Chandigarh

PGIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT02023411 - Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot | Biotech Hunter | Biotech Hunter